REFRACTORY/RELAPSE NEUROBLASTOMA

Clinical trials for REFRACTORY/RELAPSE NEUROBLASTOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY/RELAPSE NEUROBLASTOMA trials appear

Sign up with your email to follow new studies for REFRACTORY/RELAPSE NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kids with tough cancers: experimental drug trial begins

Disease control Recruiting now

This early-stage trial is testing a new drug called GAIA-102 in children and young adults (ages 1-24) whose cancers have come back or haven't responded to standard treatments. The main goal is to find a safe dose and see how well the body tolerates GAIA-102, both by itself and wh…

Matched conditions: REFRACTORY/RELAPSE NEUROBLASTOMA

Phase: PHASE1 • Sponsor: Kyushu University • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

REFRACTORY/RELAPSE NEUROBLASTOMA

Get alerted when new REFRACTORY/RELAPSE NEUROBLASTOMA trials appear

New hope for kids with tough cancers: experimental drug trial begins